Improving Binding Specificity of Pharmacological Chaperones That Target Mutant Superoxide Dismutase-1 Linked to Familial Amyotrophic Lateral Sclerosis Using Computational Methods
Open Access
- 16 March 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (7), 2709-2718
- https://doi.org/10.1021/jm901062p
Abstract
We recently described a set of drug-like molecules obtained from an in silico screen that stabilize mutant superoxide dismutase-1 (SOD-1) linked to familial amyotrophic lateral sclerosis (ALS) against unfolding and aggregation but exhibited poor binding specificity toward SOD-1 in presence of blood plasma. A reasonable but not a conclusive model for the binding of these molecules was proposed on the basis of restricted docking calculations and site-directed mutagenesis of key residues at the dimer interface. A set of hydrogen bonding constraints obtained from these experiments were used to guide docking calculations with compound library around the dimer interface. A series of chemically unrelated hits were predicted, which were experimentally tested for their ability to block aggregation. At least six of the new molecules exhibited high specificity of binding toward SOD-1 in the presence of blood plasma. These molecules represent a new class of molecules for further development into clinical candidates.Keywords
This publication has 59 references indexed in Scilit:
- Structures of the G85R Variant of SOD1 in Familial Amyotrophic Lateral SclerosisOnline Journal of Public Health Informatics, 2008
- SOD1 and Amyotrophic Lateral Sclerosis: Mutations and OligomerizationPLOS ONE, 2008
- Metalation of the Amyotrophic Lateral Sclerosis Mutant Glycine 37 to Arginine Superoxide Dismutase (SOD1) Apoprotein Restores Its Structural and Dynamical Properties in Solution to Those of Metalated Wild-Type SOD1Biochemistry, 2007
- How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?Trends in Biochemical Sciences, 2007
- Cell based screening of inhibitors of transthyretin aggregationBiochemical and Biophysical Research Communications, 2006
- Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2006
- Local Unfolding in a Destabilized, Pathogenic Variant of Superoxide Dismutase 1 Observed with H/D Exchange and Mass SpectrometryOnline Journal of Public Health Informatics, 2006
- Chemical Chaperones and Permissive Temperatures Alter the Cellular Localization of Gaucher Disease Associated Glucocerebrosidase VariantsACS Chemical Biology, 2006
- Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher diseaseCellular and Molecular Life Sciences, 2006
- Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesisAmyloid, 2006